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Fundamental studies of functional nucleic acids:
aptamers, riboswitches, ribozymes and DNAzymes
Ronald Micura *a and Claudia Ho¨bartner *b
This review aims at juxtaposing common versus distinct structural and functional strategies that are applied
by aptamers, riboswitches, and ribozymes/DNAzymes. Focusing on recently discovered systems, we begin
our analysis with small-molecule binding aptamers, with emphasis on in vitro-selected fluorogenic RNA
aptamers and their different modes of ligand binding and fluorescence activation. Fundamental insights are
much needed to advance RNA imaging probes for detection of exo- and endogenous RNA and for RNA
process tracking. Secondly, we discuss the latest gene expression–regulating mRNA riboswitches that
respond to the alarmone ppGpp, to PRPP, to NAD+, to adenosine and cytidine diphosphates, and to precur-
sors of thiamine biosynthesis (HMP-PP), and we outline new subclasses of SAM and tetrahydrofolate-binding
RNA regulators. Many riboswitches bind protein enzyme cofactors that, in principle, can catalyse a chemical
reaction. For RNA, however, only one system (glmS ribozyme) has been identified in Nature thus far that
utilizes a small molecule – glucosamine-6-phosphate – to participate directly in reaction catalysis (phospho-
diester cleavage). We wonder why that is the case and what is to be done to reveal such likely existing cellular
activities that could be more diverse than currently imagined. Thirdly, this brings us to the four latest small
nucleolytic ribozymes termed twister, twister-sister, pistol, and hatchet as well as to in vitro selected DNA and
RNA enzymes that promote new chemistry, mainly by exploiting their ability for RNA labelling and nucleoside
modification recognition. Enormous progress in understanding the strategies of nucleic acids catalysts has
been made by providing thorough structural fundaments (e.g. first structure of a DNAzyme, structures of
ribozyme transition state mimics) in combination with functional assays and atomic mutagenesis.
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Introduction
Nature has endowed nucleic acids, both DNA and RNA, with
fascinating properties that allow them to fold into complex
three-dimensional structures forming the basis for their func-
tional diversity and reactivity.1–3 RNA and DNA cannot only
mould pockets to recognize small molecules with high specifi-
city and selectivity,4 they also possess the inherent propensity
for structural ambiguities and alterations in shape which are
frequently applied as the molecular basis for distinct signalling
pathways in the cell.5,6 Additionally, nucleic acids are dynamic
in structure on timescales that vary from milliseconds to
minutes and even hours which is crucial for ligand recognition
and discrimination on the one hand (fast events),7–9 and on
the other hand, for folding/refolding of alternative secondary
structures (slower events), such as terminator/antiterminator
stem formation to regulate gene expression.10 On top, these
structural and dynamic properties are key to triggering reactivity,
culminating in the occurrence of nucleic acids catalysts.11,12
With regard to structural diversity and reactivity, RNA is
often deemed the more powerful sibling of DNA. This impres-
sion originates from the many naturally occurring representa-
tives in form of non-coding RNAs with important cellular
functions (e.g. riboswitches).4 Nevertheless, many functional
nucleic acids, RNA and DNA, have been generated artificially in
the test tube and are not limited to the functions found in
Nature. The activities of ligand binding (sensors) and catalysis
(ribozymes, DNAzymes) have been combined in aptazymes,13,14
although the currently known combinations are mostly limited
to triggering ‘‘simple’’ reactions, namely phosphodiester
cleavage or ligation. Only few artificial nucleic acids have been
identified, which employ small molecules such as nicotinamide
adenine dinucleotide (NAD+/NADH) or thiamine as cofactors.
However, these ribozymes use synthetic substrates that were
fine-tuned for the in vitro selection process.15,16 Thus far, nucleic
acids that are able to conduct reactions equivalent to modern
cellular transformations, for instance, selective methylation in
trans, using cofactors such as cobalamine or S-adenosyl methio-
nine (SAM),17 or any other natural methyl group donor, have not
yet been identified. Finding such reactivity would have a major
impact on the (protein-free) RNA world hypothesis and prebiotic
chemistry.18,19
In the laboratory, functional nucleic acids are identified by
in vitro selection (also known as SELEX) starting from random
RNA libraries. The concept was introduced by the Szostak20 and
Gold21 research groups about 30 years ago, and consists of
repeated cycles of selection and amplification for the enrich-
ment of RNA sequences with desired functions. The functions
range from specific non-covalent interactions with small and
large molecules to catalysing various chemical reactions of
diverse substrates. Although there are numerous successful
examples known today, and the procedures are constantly
refined and expanded by modern technologies,22–24 the out-
come of in vitro selection (also known as SELEX) is still highly
unpredictable. Moreover, it is currently impossible to design
functional nucleic acids from first principles. Fundamental
biochemical and biophysical studies of the NAs provide much
needed data on the thermodynamic and kinetic levels. High
throughput methods reveal insights into folding and activity
landscapes at an impressive pace.25,26 Combined with machine
learning approaches, these methods may form the basis for new
algorithms to generate aptamer and ribozyme candidates in silico,
and to derive guidelines for the evolution of high selectivity, high
rate acceleration and multiple turnover. In the protein world,
important steps in this direction have been successfully demon-
strated, with the de novo design of protein folds, enzymes, logic
gates andmolecular switches.27–30 Similar exciting advances are to
be expected in the field of nucleic acids research.31,32
This review summarizes recent developments in the fields of
in vitro selected fluorogenic RNA aptamers and riboswitch
discovery, and discusses more intensively the structures and
mechanistic elucidations of recently discovered natural ribozymes,
which we contrast with in vitro selected DNAzymes catalysing
phosphodiester cleavage and ligation chemistry (Fig. 1).
Fluorogen-activating RNA aptamers
Organic chromophores have been early targets for the in vitro
selection of RNA aptamers.20,33 The successful discrimination
of closely related structural analogues of anthraquinone dyes
was demonstrated by large differences in binding affinity.
The Reactive Blue A and sulforhodamine-binding aptamers
constituted early examples of specific recognition of anionic
ligands despite the polyanionic nature of RNA. About 10 years
later, based on the crystal structure of the Malachite green
aptamer,34 it was recognized that ligand binding resulted in
restricted conformational freedom of the ligand and this
observation culminated in the discovery of strong fluorescence
enhancement by the malachite green and sulforhodamine-
binding aptamers.35
In the last decade, fluorescence turn-on aptamers have been
an emerging class of synthetic functional nucleic acids for RNA
tracking and visualization in cellular and molecular biology.
Also termed fluorescent light-up probes, or fluorogen-activating
aptamers (FLAPs), an increasing number of in vitro evolved
Fig. 1 Overview of classes of functional nucleic acids (with selected
examples) covered in this review and their interconnections.
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30 to 100 nt long RNAs are now known to activate the fluores-
cence of various classes of conditional fluorophores. Most
of the recent examples and their applications have been
summarized in excellent reviews.3,36–39 Here, we focus on
different mechanisms and structural principles of fluorescence
activation and discuss open challenges to be addressed by
fundamental biophysical studies in combination with further
evolution and engineering.
HBI-binding aptamers – Spinach, Broccoli, Corn, Chili
The first aptamer in the family of ‘‘RNA mimics of green
fluorescent protein (GFP)’’ was named spinach.40 It was selected
to bind the difluorinated analogue of the GFP chromophore,
named DFHBI (Fig. 2A). The Spinach RNA binds the deproto-
nated ligand, and the emission wavelength and quantum yield
resemble enhanced GFP. Broccoli is a second generation
aptamer that was selected with a modified DFHBI analogue,
DFHBI-1T, and was optimized to function in cellular conditions
at low Mg2+ concentration.41 Spinach and Broccoli RNAs share
similar primary and secondary structures, and use the same
structure-based mechanism of fluorescence activation that relies
on reducing non-radiative deactivation of the excited state. The
ligand binding site involves a guanine quadruplex of complex
topology.42,43 The ligand stacks on top of one G-quartet, and, in
spinach, it is sandwiched between the G-quartet and a base-
triple (Fig. 2B). The extended p-stacking interactions reduce the
conformational flexibility of the ligand, resulting in rigidification
and reduced conformational flexibility, thus promoting fluores-
cence emission. Although the 3D structure of Broccoli has not
been explicitly solved, it is reported to be highly related to Spinach,
and single point mutations are known to tune fluorescence
emission wavelengths and intensities, as well as RNA folding
kinetics.44–46 In vitro evolution of Spinach based on microfluidic
screening of water-in-oil droplets resulted in a variant named
iSpinach,47 with reduced salt-sensitivity, higher thermal stability
and increased brightness, despite containing an almost identical
core structure of the quadruplex in the ligand binding site.48
Another quadruplex-containing aptamer named corn was
obtained in an in vitro selection experiment with an extended
derivative of DFHBI that carries an oxime sidechain, named
DFHO.49 Corn differs from Spinach and Broccoli not only in the
redshifted emission wavelength and enhanced photostability,
but also in the architecture of the ligand binding site.50 Spinach
and Broccoli are monomeric aptamers, while Corn forms a
dimer, and the ligand is bound at the interface of the two
interacting RNA molecules (Fig. 2C).50 Interestingly, the quad-
ruplex dimer is also formed in the apo state (i.e., in the absence
of the ligand), with a collapsed, symmetric conformation.51
Moreover, structures of Corn in complex with the quadruplex-
binders thioflavin T (ThT) and thiazol orange (TO) helped to
rationalize their strong fluorescence activation by binding to
the Corn quadruplex dimer.51
Spinach, Broccoli and Corn bind fluorinated HBI analogues
with low pKa values that are easily deprotonated and exist
predominantly as phenolates under physiological conditions.
In contrast, the Chili aptamer,52 which is derived from
the earlier reported 13-2 aptamer,40 binds and activates the
dimethoxy-substituted analogue DMHBI exclusively in the
protonated state. The phenolic proton is lost upon excitation
of the bound ligand, resulting in fluorescence emission from
the phenolate form. The excited state proton transfer (ESPT)
leads to the large Stokes shifts of 4130 nm observed in Chili.
Moreover, Chili is able to activate the emission of several
ligands with different substitution patterns, resulting in
fluorescence emission in the green, yellow and red wavelength
range.53 The introduction of a permanent positive charge in the
ligand sidechain in DMHBI+ and DMHBO+ led to strongly
enhanced affinities, and maintained high selectivity for the
Chili aptamer. The structure of any Chili RNA–ligand complex
has not yet been reported. However, the high guanine content
(48% G), and preliminary NMR spectra suggest the presence of
a quadruplex core structure.42,53 Initial hints into the organiza-
tion of the aptamer and the relative location of the ligand were
obtained by supramolecular FRET.54 The fluorescent nucleo-
base analogue 4-cyanoindol was covalently incorporated into
the RNA aptamer and served as donor for energy transfer to the
non-covalently bound DMHBI+/DMHBO+ ligands that served
as acceptor.54 Additional fundamental studies of ESPT photo-
physics in combination with structural studies may reveal the
identity and function of the proton acceptor. Preliminary data
regarding the involvement of a crucial nucleobase nitrogen
have been obtained by mutagenesis experiments, but more
detailed investigations are needed to surface the mechanism
of how Chili mimics the large Stokes shift (LSS) fluorescent
proteins, such as LSSmOrange and LSSmKate.55
Fig. 2 Fluorogen-activating RNA aptamers. (A) HBI ligands of Spinach,
Broccoli, Corn and Chili. (B) Core of iSpinach with DFHBI sandwiched
between G-quartet (blue, cyan) and UAU base triple (orange), held in place
by H-bonding with guanine and methyl p interaction with adenine
(magenta). (C) Dimeric quadruplex of Corn with H-bonding contacts to
the oxime side chain and phenolate oxygen. (D) Ligand structures for
Mango, DIR2s, and Pepper aptamers.
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TO-binding aptamers – Mango
The second heavily investigated and structurally well-characterised
class of fluorogenic aptamers is the Mango family, which binds
to derivatives of thiazole orange (TO). Originally selected to bind
biotinylated TO1 with a PEG linker,56 four generations of the
Mango aptamer were evolved by advanced methods, including
fluorescence-activated droplet sorting.47,57,58 The structures of
Mango variants from generations I–IV are known, and have
recently been discussed in detail.3,58–61 The core of all Mango
aptamers contains a G-quadruplex, primarily responsible for
stacking and rigidification of the bound ligand. While the first
generation included the PEG linker and the biotin in packing
onto the G-quartet next to TO1,61 later generations exhibited
improved fluorophore planarity resulting in higher brightness.
Mango-III and iMango-III exhibited additional sophisticated
structural elements, such as an unusual pseudoknot structure
containing non-canonical trans base pairs in parallel strand
orientation.58,62
Additional recent light-up aptamers
Besides HBI- and TO-binding aptamers described above,
several other aptamers have recently been reported to enhance
the brightness of conditional fluorophores. These include the
DIR2s aptamer that binds asymmetric cyanine dyes such as
dimethylindole red (DIR) and oxazole thiazole blue (OTB).63
Interestingly, this aptamer does not form a G-quadruplex core
for planarization of the fluorophore, but instead uses a mixed-
sequence tetrad to promote rigidification, supported by a single
adenine stacking on top of the thiazole ring.64
The most recent ‘‘spicy’’ addition to the family of fluoro-
genic vegetable and fruit aptamers for RNA imaging is the
Pepper aptamer.65 The small ca. 45 nt long RNA binds and
activates a family of eight related synthetic dyes, derived from
substituted aminobenzylidene cyanophenyl acetonitriles (HBC,
Fig. 2D) that exhibit a structurally rigid electron acceptor and a
strong electron donor to produce emission colours in the range
from cyan to red. Structural analysis of the predicted bulged
stem-loop core will likely reveal the molecular basis of this
colourful diversity. To avoid confusion, it should be noted that
a second strategy for RNA tracking was recently introduced
under the name Pepper RNA, which follows a very different
mechanism based on RNA-mediated stability of a fluorescent
protein.66
A different fluorogenic mechanism is employed by the
recently reported silicon rhodamine-binding RNA aptamer
(SiRA).67 Specific binding of silicon rhodamine to the RNA
shifts the equilibrium between the closed non-colored spiro-
lactone and the open fluorescent zwitterion, resulting in turn-on
of NIR fluorescence emission.
Besides fluorophore rigidification, another common mecha-
nism of fluorescence enhancement is the RNA-based disruption
of chromophore–quencher conjugates. In this case, binding of
RNA aptamers either to the fluorophore or to the quencher results
in enhanced emission. Early examples include non-emissive
fluorescein derivatives with 4-methoxyphenyl-piperazinyl side
chains that served as donors by photoinduced electron transfer
(PET).68 Aptamers have been evolved for selective binding of
black-hole-quenchers to eliminate contact-mediated quenching
of fluorescence.69,70 Other rationally designed fluoromodules
used rhodamine dyes with appended dimethylaniline or dinitro-
aniline quenchers.71 The SRB-2 aptamer, termed rainbow, then
allowed for dual colour fluorogenic RNA imaging with low back-
ground in live cells.72,73 Another recently introduced concept takes
advantage of self-quenching upon fluorophore dimerization. A cell-
permeable fluorogenic dimer of sulforhodamine B (Gemini-561)
was used for the in vitro selection and resulted in the dimeric
o-Coral aptamer with enhanced performance for RNA imaging.74
The first example of a natural aptamer that was repurposed
for the development of a fluorogenic RNA imaging platform
was the cobalamin riboswitch.75 Cobalamin served as fluores-
cence quencher when appended to different fluorescent dyes,
and binding to the RNA elicited fluorescence enhancement due
to reduction of contact quenching. This strategy holds promise
for engineering of differently coloured fluoromodules with
high affinity. However, the relatively high background of the
Riboglow platform is an inherent difficulty encountered in
systems that rely on contact quenching in solution.
Riboswitch RNAs
Riboswitches are utilized by bacteria to sense metabolites and
ions in order to regulate gene expression. To date, riboswitches
that respond to nearly fourty distinct small ligands have been
discovered and experimentally validated.76,77 For most of them,
X-ray crystallography has revealed the three-dimensional struc-
tures of their ligand-binding aptamer domains, shedding light
on the enormous diversity of RNA folds and RNA recognition
patterns.78–80 The first riboswitch validation reports date back to
200281–84 and covered riboswitches that are very common and are
present in bacteria from nearly all lineages. They respond to
thiamine pyrophosphate, cobalamine, adenine, guanine, S-adenosyl-
methionine, glycine, lysine, cyclic diguanylate, and many more.
Other riboswitches are exceedingly rare and appear in only a few
species. Nearly all of the currently known riboswitches have been
identified by a single laboratory (Ronald R. Breaker). They predict
that there are potentially many thousands of distinct bacterial
riboswitches remaining to be discovered.76 Recent articles on ribos-
witch diversity and distribution cover biocomputational aspects,76,77
several reviews summarize their structural concepts,78–80 and some
focus on latest developments to use riboswitches as sensor tools in
biotechnological and biomedical applications.10,14,85–90
Here, we concisely focus on the most recent additions to
riboswitches (Fig. 3) and on a few reports that aim at utilizing
riboswitch scaffolds to engineer ligand specificities and chemical
reactivity towards systems that function as riboswitch–ribozymes.
Recent additions to natural riboswitch systems
Xanthine riboswitch. The most recent discovery of a bacterial
riboswitch class that has been assigned to a novel ligand is the
xanthine riboswitch.91 Its consensus sequence forms a hairpin
Review Article Chem Soc Rev
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
8 
Se
pt
em
be
r 2
02
0.
 D
ow
nl
oa
de
d 
on
 9
/2
8/
20
20
 1
0:
59
:1
7 
A
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
This journal is©The Royal Society of Chemistry 2020 Chem. Soc. Rev.
structure with an internal bulge that includes numerous highly
conserved nucleotides and was originally annotated as an orphan
riboswitch candidate with NMT1 motif. Members of the xanthine
riboswitch class regulate genes predominantly related to purine
transport and oxidation, thus avoiding the effects of overproduc-
tion of these common purine metabolites (Fig. 3).
NAD+ riboswitch. The nadA riboswitch is present in various
Acidobacteria species with more than hundred representatives
identified upstream of nadA genes.92 These code for an enzyme
in the biosynthetic pathway of the ubiquitous coenzyme
nicotinamide adenine dinucleotide (NAD+). The consensus
secondary structure fold of this RNA implies two structurally
related ligand-binding aptamers which control translation
initiation. Biochemical analyses suggested that the first
domain selectively binds ligands containing an adenosine
50-diphosphate (ADP) moiety. A recent crystal structure of the
first aptamer domain shows an open binding site for selective
recognition of the adenine base, and Mg2+-mediated inter-
action with the pyrophosphate moiety.93 Interestingly, the
nicotinamide portion of NAD+ is solvent-exposed. Binding of
NAD+ to the second putative aptamer appears very weak in vitro
despite sequence and structural similarities between the
tandem domains. Further structural work on the second
domain and the full tandem aptamer is required to understand
the mode of recognition and its precise function.
In this context, we stress that the NAD+ aptamer discrimi-
nates NAD+ over NADH by a factor of about two, while NADP+ is
not binding to this RNA. The assignment to NAD+ as cognate
ligand was based on the higher cellular concentration of NAD+
(B2.6 mM) compared to NADH (B120 mM) in bacteria.92
Furthermore, it cannot be excluded that a riboswitch exists
for NADP as well, however, such an RNA motif is likely distinct
from the NAD+ motif because the 20-OH is tightly recognized in
the pocket by H-bonding93 and a 20-OPO3
2 group (as present in
NADP+) would cause steric interference.
4-Amino-5-hydroxymethyl-2-methylpyrimidine diphosphate
(HMP-PP) riboswitch. The thiS motif was identified as a ribos-
witch candidate frequently associated to genes involved in the
vitamin B1 synthesis pathway. The ThiS protein is responsible
for delivering sulfur to form the thiazole moiety of the thiamine
precursor 5-(2-hydroxyethyl)-4-methylthiazole phosphate (HET-P).
Biochemical and genetic data demonstrated that thiS RNAs
function as sensors of the required second thiamine precursor
HMP-PP to turn on HET-P production. HMP-PP and HET-P are
then fused to ultimately form the final active coenzyme thiamine
pyrophosphate (TPP).94 The small ligand-sensing aptamer
domain of the HMP-PP riboswitch (ca. 30 nt) is almost entirely
embedded in a transcription terminator stem. Such a situation
has not been observed before in other transcriptionally con-
trolled riboswitches, which require individual aptamer domains
with a competing secondary structure element that adjoins (and
partially overlaps with) the terminator sequence.
Guanidine riboswitches (ykkC RNA subtype 1). Comparative
genomics also led to the prediction of the ykkC RNA motif as a
riboswitch candidate. It resisted initial efforts at experimental
verification and remained orphan for a very long time.95 Today,
it is known that the ykkC motif includes at least five distinct
bacterial riboswitch classes. The ykkC subtype 1 RNAs are
guanidine-I riboswitches that regulate the expression of guanidine-
specific carboxylase and transporter proteins.96–102
Guanosine tetraphosphate (ppGpp) riboswitch (ykkC RNA
subtype 2a). The remaining ykkC RNAs have been categorized
into four major groups termed subtypes 2a–2d. Subtype 2a RNAs
are riboswitches that respond to the bacterial alarmone ppGpp
and they typically control genes for amino acid biosynthesis.103
Phosphoribosyl pyrophosphate (PRPP) riboswitch (ykkC
RNA subtype 2b). This riboswitch senses the purine biosyn-
thetic intermediate PRPP and frequently partners with guanine
riboswitches to regulate purine biosynthesis genes.95 How ykkC
riboswitches discriminate ppGpp from PRPP ligands was
disclosed in recent crystallographic structural studies.104,105
Subtype 2b RNAs employ an add-on helix to adjust specificity
for the polyanionic ligands.105
Adenosine and cytidine 50-diphosphate riboswitches (ykkC
RNA subtype 2c). These RNA motifs are located upstream
of genes encoding hydrolase enzymes that cleave the phos-
phoanhydride linkages of nucleotide substrates. Representa-
tives of subtype 2c mostly sense adenosine and cytidine
50-diphosphates (ADP, dADP, CDP, and dCDP), while the corres-
ponding nucleoside 50-triphosphates are not responding.106
High ligand concentrations in vivo are predicted to turn on
the production of hydrolase enzymes, which may function to
balance the concentrations of cellular nucleotides, but elucida-
tion of the switching mechanism requires further investigation.
Fundamental structural studies and their comparison to in vitro
selected, 50-triphosphate-binding ATP/GTP aptamers107,108 are
needed and expected to uncover similarities or differences
Fig. 3 Ligands of recently discovered bacterial mRNA riboswitch classes.
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in evolution of ligand discrimination in Nature and in the
laboratory.
SAM riboswitches. Although SAM riboswitches belong to the
group of riboswitches that were discovered first,109,110 a new
subclass has been identified recently.111 The SAM-VI riboswitch
adopts a new fold that recognizes its ligand in a distinct manner
compared to the previously known five SAM riboswitch
classes.112
Tetrahydrofolate riboswitches. The folE motif RNAs selec-
tively interact with the ubiquitous cofactor tetrahydrofolate
(THF) and are commonly found in Gram-negative bacteria.113
Biochemical validation of these aptamers demonstrated that
they are distinct from aptamers of the previously validated THF
riboswitch class found in Gram-positive bacteria.114 They
define a second THF riboswitch class, named THF-II.
Riboswitch goes ribozyme – and an outlook on non-protein
RNA methyltransferases
Many riboswitches bind protein enzyme cofactors that can
catalyse or mediate chemical reactions.115,116 Thus far, however,
only one RNA system (glmS riboswitch–ribozyme) has been
identified in nature that utilizes a small molecule – namely
glucosamine-6-phosphate – to participate directly in reaction
catalysis (phosphodiester cleavage).117 We wonder why not more
such examples have been found and what we have to undertake
to disclose these likely existing cellular activities that could be
more widespread than currently imagined. Moreover, in the
hypothetical RNA world,118–122 ribozymes with the capability to
conduct more diverse reactions in a primitive cell might have
taken the role of today’s protein enzymes. Such ribozymes could
have evolved from riboswitches, thereby utilizing the aptamer
binding pockets for proper positioning of substrates and
cofactors. A recent study delineates such a pathway for the
evolution of an aminoacylation ribozyme which could be part
of a primitive translation system.123
An aminoacylation ribozyme evolved from a natural tRNA-
sensing T-box riboswitch. The naturally occurring T-box ribo-
switches selectively sense the aminoacylation status of cognate
tRNAs.124 Suga and coworkers introduced a random sequence
domain into a T-box–tRNA conjugate and selected ribozymes
that aminoacylated their own the 30-terminal hydroxy groups.123
One of these ribozymes recognizes the anticodon and D-loop of
tRNA comparably to the parental T-box. It charges biotinylated
phenylalanine onto the 30 end of the cognate tRNA in trans with
very high selectivity. The authors further showed the ribosomal
synthesis of a biotinylated peptide in a ribozyme-coupled in vitro
translation system, in which the ribozyme catalysed specific
tRNA aminoacylation in situ.
Riboswitch motifs as scaffolds for genetically encodable
small-molecule biosensors. The advantage of utilizing natural
scaffolds for aptamer selections has been convincingly demon-
strated by a recent study: Although aptamers can be created
de novo against almost any desired target through in vitro
selection, most of them are not easily integrated into tools
for molecular or synthetic biology. To overcome this bottle-
neck, Batey and coworkers developed an approach using
secondary- and tertiary-structural scaffolds derived from
purine and cyclic di-GMP riboswitches, and the hammerhead
ribozyme.125 When applied to precursor molecules (namely,
5-hydroxytryptophan and 3,4-dihydroxyphenylalanine) of the
neurotransmitters serotonin and dopamine, this approach
yielded easily identifiable and characterisable aptamers. The
sensor domains were coupled to readout domains and allowed
engineering of powerful nucleic acid–sensory devices for in vitro
and cellular applications.
Building selection strategies on natural riboswitch scaffolds
could also impact the field of ‘aptazymes’,14,126,127 namely the
development of allosteric RNA devices that currently predomi-
nantly rely on de novo selected small molecule aptamers
(e.g. theophylline, tetracycline, etc.) with adjoining self-cleaving
small ribozymes of natural origin (hammerhead, HDV, twister,
pistol, etc.).128–130 Such allosteric RNA devices are increasingly
being regarded as effective tools for monitoring enzyme evolution,
optimizing engineered metabolic pathways, modulating splicing,
facilitating gene discovery, and as regulators of nucleic acid–based
therapeutics, including next-generation gene therapy.
Due to the limited understanding of context-dependent
structure–function relationships, the identification of func-
tional riboswitch devices can be significantly advanced by
large-scale-screening of aptamer-effector-domain designs. The
latter is often impeded by the lack of appropriate cellular high-
throughput methods.
High-throughput identification of synthetic riboswitches.
A fast and broadly applicable method was recently described
to functionally screen complex riboswitch libraries in a cellular
high-throughput approach. The authors used cDNA-amplicon-
sequencing to count conditionally expressed mRNAs in transiently
transfected and ligand-stimulated human cells.131 In contrast
to other methods, the new self-barcoding strategy of each
riboswitch library member avoided the need for additional
cDNA-manipulation steps to introduce external sequencing
barcodes. This method was demonstrated for engineering
of guanine- and tetracycline-responsive off- and on-switches
utilizing twister, hepatitis delta virus, and hammerhead ribo-
zymes as well as U1-snRNP polyadenylation-dependent RNA
devices.
Towards the identification of cofactor-based RNA methylation
tools – impact on RNA epitranscriptomics, and the RNA world
hypothesis. Despite intensive research on allosteric RNA devices,
examples that involve advanced chemical reactions such as
methylations based on binding of a biological methylation agent
(e.g. SAM, methyl cobalamin, or methylene tetrahydrofolate) to
RNA aptamer domains and subsequent reaction using the bound
cofactor have not yet been identified. Given the large number of
naturally occurringmethylated nucleosides in tRNA, rRNA, snRNA,
and mRNA, the assumption of a potential existence of catalytic
RNA with methyltransferase activity is intriguing. Thus far, only
self-alkylation reactions involving a-iodo- or a-chloroacetamide
moieties,132–134 or more recently, epoxide ring-opening135 were
successfully utilized for in vitro selection of RNA biotinylation
and labelling tools, although the reaction times were up to
48 hours to give yields below 50%.135
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RNA harbours all structural and functional requirements to
bind small molecules and to catalyse more complex chemical
reactions beyond phosphodiester cleavage. In particular, the
identification of RNA methylation tools seems to be at hand,
however, this has not yet been demonstrated, neither by in vitro
selection, nor by identification of an existing cellular system
(Fig. 4). Finding evidence for both would have a tremendous
impact on the RNA world hypothesis and prebiotic chemistry,
on RNA epitranscriptomics, and on biotechnological RNA tool
development.
Catalytic nucleic acids – ribozymes &
DNAzymes
Both RNA and DNA can fold into structures that catalyse
chemical reactions. For naturally occurring systems, these
reactions mostly concern RNA phosphodiester cleavage and
ligation, besides peptide bond formation in the peptidyl trans-
ferase center of the ribosome,136 while no examples for naturally
occurring catalytic DNAs are known thus far.137,138 With respect to
in vitro selected RNA and DNA, the scope of reactions that can be
catalysed is much broader, including N7 alkylations (mentioned
above),132,135 aminoacylations,26,139,140 Michael additions,141
Diels–Alder reactions,142,143 and many more.137,144
Below we will focus on recent developments in the field
of phosphodiester-cleaving and -forming ribozymes and
DNAzymes only.
Small self-cleaving ribozymes
The first ribozymes were discovered by Thomas Cech and
Sidney Altman in the eighties and this finding changed the
paradigm that proteins were the sole catalytic molecules in
living organism. Earlier, RNA was considered to be information
carrier (messenger RNA, mRNA), structural scaffold of the
ribosome (ribosomal RNA, rRNA), and interface between them
as amino acid transporter and decoder (transfer RNA, tRNA).
RNA’s functions, however, go well beyond these tasks, and
ribozymes represent one important class of naturally occurring
functional RNAs. Most of them catalyse RNA backbone cleavage
or the converse, RNA ligation. Ribozymes can be grouped into
splicing ribozymes and cleaving ribozymes,145 with the latter
divided further into trans-cleaving ribonuclease P,146 and small
self-cleaving (or ‘nucleolytic’) ribozymes. To date, nine distinct
small self-cleaving ribozyme classes have been described,
including hairpin,147–150 hammerhead,151–155 hepatitis delta virus
(HDV) and HDV-like motifs,156–159 glucosoamine-6-phosphate
synthase (glmS),117,160,161 and Neurospora Varkud satellite
(VS).162,163 More recently, twister,164 twister sister,165 hatchet,165 and
pistol165 motifs have been added.
Concerning the biological function of small self-cleaving
ribozymes in living systems, rather little is known.166 For
instance, HDV ribozymes promote their own cleavage from the
transcript during rolling circle replication of the hepatitis delta
virus. Also hairpin and VS ribozymes are connected to viral
genome replication.167 The function of hammerhead ribozymes
with thousands of representatives in diverse organisms is less
clear. A role during pre-mRNA biosynthesis is conceivable but
other putative biological functions are mainly linked to the
genomic context and hence remain speculative.166
Numerous chemical, biochemical, and biophysical studies
have been performed, that can be compared and contrasted
with structural studies of most ribozymes, usually based on
X-ray crystallography.166–173 Small self-cleaving ribozymes con-
duct site-specific internal transesterification which involves the
ribose 20-hydroxy group adjacent to the scissile phosphate.
Through a SN2-type mechanism, a penta-coordinated phos-
phorane transition state is passed,174 and finally results in
two products. The product RNA 50 of the scissile phosphate
retains this phosphate in form of a 20,30-cyclic phosphate while
the 30 RNA product obtains free hydroxyl termini. To support
the reaction, the ribozyme can engage up to four potential
strategies (Fig. 5).175–177 First, the 20-oxygen, phosphor, and
50-oxygen atoms should ideally lie on a straight line for nucleo-
philic attack (a catalysis);178 second, the enhanced negative
charge on the nonbridging phosphate oxygens in the transition
state should be electrostatically compensated (b catalysis);
third, the proton from the attacking 20-OH nucleophile should
be removed (g catalysis – general base catalysis); and fourth, the
developing negative charge on the 50 oxygen leaving group
should be neutralized by donating a proton (d catalysis, general
acid catalysis) (Fig. 5). Recently an advanced ontology was
developed for discussion of these strategies that refines this
established framework into primary, secondary, and tertiary
Fig. 4 S-Adenosylmethionine (SAM). (A) Chemical structure of the cofactor
and known reactivities (grey shadow) and protein-enzyme mediated
reaction products of SAM with RNA targets. (B) Hypothesis for RNA-
catalysed methylation reactions using SAM as cofactor in a prebiotic
RNA world.
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contributions to enable a more precise description of the
reaction mechanism with respect to structure and bonding.179
Moreover, the cleavage of the phosphodiester bond is not
necessarily concerted. The transesterification process can pro-
ceed stepwise involving transition states that are ‘tight’ and
asynchronous.174,181 The individual architectures of the active
sites encountered in distinct ribozyme classes determine the
reaction pathway and transition states and these features are
responsible for the broad range of cleavage rates, spanning
several orders of magnitude (o0.1 h1 to 41 s1).
For protein-based enzymes, the structurally distinct side
chains of 21 amino acids provide sufficient diversity to con-
tribute to reaction catalysis.176 In contrast, the four nucleosides
in ribozymes offer a limited scope of functionalities that affects
electrostatic catalysis and general acid–base catalysis at neutral
pH. Due to the fact that ionization of the nucleobases and the
20-OH of the ribose requires rather harsh acidic or basic
conditions, the first reports thus suggested ribozymes to rather
be metalloenzymes with the RNA serving as scaffold to place
hydrated Mg2+ ions as effectors.182,183 Later, it was found that
many self-cleaving ribozymes are functional in the absence of
divalent metal cations. Experimental evidence was collected for
pKa-shifted active site nucleobases that participate directly in
catalysis in some ribozymes, and nowadays, the general acid–
base catalysis is a widely accepted concept for rate enhance-
ment in small self-cleaving ribozymes.167,184 Nevertheless,
direct effects of pH and metal ions on ribozyme catalysis are
usually difficult to distinguish from indirect effects on folding
(and fold stabilization) of a ribozyme and require advanced and
careful experimentation.176
In the years 2014 and 2015, the ribozyme field was reinvigorated
by two studies describing the identification of four novel ribozymes,
termed twister,164 twister sister,165 pistol,165 and hatchet.165 These
discoveries initiated comprehensive investigations applying modern
experimental and computational approaches to further increase our
understanding of ribozyme-mediated catalysis.
Twister ribozyme
Among the four most recently discovered ribozymes, twister has
been investigated most intensively by biochemical,164,165,185
structural,186–189 and chemical189 approaches providing insights
into the topological constraints contributing to catalysis. The
clear distinctions observed in the active site and the P1 segment
of the available crystal structures left room for miscellaneous
interpretations and speculations. In particular, the observation
of Mg2+ ions in inner-sphere coordination to the scissile phos-
phate in two of the structures caused debates on their relevance
for catalysis (Fig. 6).190–192 Analysis of thio effects and metal ion
rescues for phosphorothioate substrates assigned them a minor
role.189,193 Key functions, however, can be attributed to con-
served nucleosides in the active site, namely a guanine and the
adenine directly at the cleavage site, both involved in general
acid–base catalysis. Interestingly, for the adenine, the crucial
site of protonation in its role of d catalysis was narrowed down
to the N3 position in the architectural framework of the
ribozyme, distinct to the usually preferred N1 protonation site
of adenosine.189,193,194
Another insightful perspective was provided by recent studies
that analysed the d catalysis role of this adenine via chemical
rescue.195,196 Using inhibited twister ribozyme variants with 1- and
3-deazaadenosine modifications, the authors observed significant
chemical rescue effects in the presence of small molecules such as
imidazole and histidine. Brønsted plots for the twister variants
supported a model in which small molecules rescue catalytic
activity via a proton transfer mechanism, suggesting that the
conserved adenosine directly at the cleavage site in the wild type
is involved in proton transfer, most likely general acid catalysis.
Additionally, it was demonstrated that an 8-bromoadenosine
modified twister ribozyme is faster than a native counterpart,
supporting crystallographic data that show that this adenosine is
in syn conformation when conducting proton transfer.
A further peculiarity of twister is that it retains wild-type
activity when the phylogenetically conserved stem P1 is deleted,
able to cleave a single nucleotide only.189 This feature was
already insinuated by the crystal structures of twister, with
two of them showing a fully base paired P1 stem (Fig. 6G)
whereas two others showed disrupted base pairs instead, with
two of the nucleobases participating through fold back in
formation of stacked base triples (Fig. 6F).190,192 A single-
molecule FRET study on twister ribozyme folding rationalizes
this behaviour by revealing that the active site-embracing
pseudoknot fold is preserved in the P1-lacking ribozyme and
in the cleaved 30-product RNA where P1 cannot form (Fig. 7).197
The rigid fold of the cleaved 30-fragment that retains its
compacted pseudoknot fold despite the absence of stem P1 is
furthermore consistent with the poor turnover efficiency of
the twister ribozyme. Taken together, the phylogenetically
conserved stem P1 is not only dispensable for cleavage activity
but also for folding into the active structure. The reason for P1
conservation remains unclear and very likely concerns features
other than chemical mechanism and formation of the cleavage-
competent ribozyme fold.
Fig. 5 Model for phosphodiester cleavage in small self-cleaving
ribozymes.180 The to-be-cleaved (‘‘scissile’’) phosphate is proposed to
form a pentacoordinate transition state by SN2-like in-line attack of the
nucleophilic 20-hydroxy group (a catalysis, blue); thereby, neutralization
of the (developing) negative charge on nonbridging phosphate oxygen
atoms (b catalysis, purple) may support, as well as deprotonation of the
20-hydroxy group (g catalysis, red) and/or neutralization of negative charge
on the 50-oxygen atom by protonation (d catalysis, green). The 50 cleavage
product carries the original phosphate in form or a 20,30-cyclic phosphate.
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Finally, a series of computational studies have followed and
further described this ribozyme, essentially supporting the above
mentioned experimental findings and interpretations.198–201
Pistol ribozyme
For the pistol ribozyme, our understanding of the catalytic
mechanism of phosphodiester cleavage has grown significantly
over the past years (Fig. 8A). Initial structural and biochemical
data hinted primarily at a general acid–base mechanism involving
purine nucleobases in the active site.165,202–204 Later, this view was
expanded because intensive atomic mutagenesis-based assays
shed light on the mechanistic role of divalent metal ions.205,206
The first three-dimensional structures of the pistol ribozyme
were available in 2016, solved by X-ray crystallographic
methods with a resolution of 2.7 Å (env25 pistol)203 and 3.0 Å
(env27 pistol),204 respectively. Both structures represent a pre-
catalytic conformation that has been trapped based on mutants
carrying a hydrogen atom instead of the native 20 OH nucleo-
phile at the cleavage site. Moreover, the two structures are in
very good agreement with respect to the overall topology and the
cleavage site alignments and implied nucleobase-mediated acid–
base catalysis of the cleavage reaction,192 involving a guanine
(G40) and seemingly, an adenine (A32) in the active site. Shortly
after, a chemical study based on atomic mutagenesis demon-
strated that a Mg2+ ion that is innersphere-coordinated to the
N7 atom of another guanine in the active site (G33) plays a key
Fig. 6 Twister ribozyme. (A) Pocket for dU–A active site in the 2.9 Å
resolution structure of the env22 twister ribozyme with emphasis on the
position of the C20 of dU relative to the P–O50 bond. (B) Pocket for dU–A
active site pocket in the 2.3 Å resolution structure of the O. sativa twister
ribozyme. (C) Secondary structure model of env22 ribozyme. (D) Current
model for the twister cleavage mechanism; major roles G48 (g catalysis)
and A6 (d catalysis via N3), minor role: hydrated Mg2+. (E) Secondary
structure model of O. sativa ribozyme. (F) Three-dimensional structure in
cartoon presentation of the dU modified env22 ribozyme and (G) the dU
modified O. sativa ribozyme. Note the differences in segment P1 (green):
‘back-folding’ of nucleosides (U1 and U4) of segment P1 for env22 to form
base triplets, and fully Watson–Crick base-paired stem P1 for O. sativa,
respectively. Black triangles indicate the cleavage positions.
Fig. 7 Twister ribozyme. (A) Alternative folding pathways to achieve
the catalytically active pseudoknot fold as derived from a comprehensive
2- and 3-color FRET study based on a series of probes with distinct label
positions.197 (B) Labelling pattern and cartoon of anticipated dynamics.
(C) Schematics of alternating laser excitation (ALEX) experiments. (D) Repre-
sentative FRET time course after stopped-flow Mg2+ addition (dotted line
indicates 2 mM final concentration).
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role in catalysis (rather than A32).205 The disruption of this
coordination site by N7-to-C7H mutation caused a 1000-fold
decrease in cleavage rate. This was reconfirmed by an indepen-
dent study.207
Very recently, additional crystal structures have been published,
providing three-dimensional snapshots that now cover further
states along the reaction coordinate of pistol phosphodiester
cleavage, representing the transition state (in form of a vanadate
mimic) (Fig. 8B) and the product (20,30 cyclophosphate).206 This
broad structural foundation resulted in a profound proposal of the
underlying chemical mechanism. Essentially, a hydrated Mg2+ ion
remains innersphere-coordinated to the N7 nitrogen of G33 in all
three states, which supports its proposed role as acid in general
acid base chemistry (d and b catalysis).206 Interestingly, a second
hydrated Mg2+ ion approaches the to-be-cleaved phosphate
from its binding site in the pre-cleavage state to stretch
out for water-mediated hydrogen bonding to one of the non
bridging oxygen atoms of the cyclophosphate product.206 The
major role of the second Mg2+ ion appears to be stabilization of
the product conformation.
Combined mechanistic scenario for pistol cleavage. In the
precatalytic pistol conformation, a divalent ion (Mg2+) becomes
innersphere-coordinated to the N7 atom of guanine G33 in the
active site and is further fixated by first shell water-mediated
hydrogen bonds, one to the 20-hydroxy group of the ribose in
position 32 (with highly conserved purine base; A or G), and the
other one to the pro-R oxygen of the scissile phosphate
(Fig. 8C). Simultaneously, guanine G40 triggers proton transfer
from the 20-hydroxy group of G53 which attacks the adjacent
phosphorus atom in-line to the P–O5 0 bond. Of note, a second
divalent Mg2+ ion (in a binding site formed by A38 and A39)
comes 3.9 Å close to the O6 of G40 and could in principle
impact the pKa of guanine G40, however, mutation of G40 to
2-aminopurine (lacking O6) did not hamper wild-type activity.
In the transition state, the nucleobase of G40 stabilizes
the phosphorane in a bidendate manner (via N1  20O and
N2  pro-R O), and at the same time, the proximity of the
divalent ion that remains innersphere-coordinated to N7 of
G33 likely lowers the energy barrier by electrostatic interactions
and by outershell coordination to the pro-R nonbridging oxygen
atom of the to-be-cleaved phosphate (Fig. 8C). This process, in
turn, locates one of its first shell water molecules (general acid)
into suitable distance for proton transfer to the 50O leaving
group. The obtained cyclophosphate becomes embedded
in a network of hydrogen bonds involving the two hydrated
Mg2+ ions coordinated to the pro-R and pro-S oxygen atom,
respectively. This assembly may stabilize a cyclophosphate
conformation that blocks ligation of the cleaved fragments
(reverse reaction). Interestingly, one of the hydrated Mg2+ ions
moves from its A38/A39 binding site in the pre-cleavage state
towards the cyclophosphate moiety in the post-cleavage state
while the other hydrated Mg2+ ion remains strictly positioned
at the N7 of G33 in all three states for executing its role in d and
b catalysis (Fig. 8D).
Comparison to other ribozymes with transition state structures.
Only two other ribozymes have been previously characterised by
crystallography of transition state analogues. Using vanadium
oxide as mimic was pioneered for the hairpin ribozyme.150
Direct interactions with the nucleobase, which seemed to stabilize
the electronic structure and geometry of the hairpin ribozyme
TS, had been revealed,150 as well as potentially involved water
molecules.208 Similar to pistol, the superposition of pre-cleavage,
Fig. 8 Pistol ribozyme. (A) Secondary structure model of the consensus
sequence. (B) Pocket for active site G53–U54 observed in the crystal
structure of a vanadate transition state mimic. Crucial atom distances
(below 4.5 Å) that indicate direct or water-mediated hydrogen bonds and/
or metal ion interactions are shown by dashed lines. The values in black are
distances in Å. Note that the number of distances can exceed the number
of possible hydrogen bonds for an atom. (C) Current model for pistol
cleavage mechanism; major roles G40 (g catalysis) and hydrated Mg2+
coordinated to N7–G33 (d catalysis), minor role: hydrated Mg2+ coordi-
nated to A38. (D) Superpositions of the pre-cleavage state (M2+ and scissile
phosphate in green color), TS analogue vanadate (cyan), and post-
cleavage state (grey), revealing the repositioning of the Mg2+ ion close
to O6 of G40 in the pre-cleavage state towards the pro-S oxygen atom of
the scissile phosphate in the cyclophosphate product.
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transition state mimic, and product structures of the hairpin
ribozyme displayed that the active site was rigid, while motion
concerned the scissile phosphate and the upstream nucleoside
sugar pucker. In contrast to the pistol ribozyme, no divalent
metal ion was observable in the active site of the hairpin
ribozyme and only nucleobases participated in the recognition
of the cleavage site.
Not long ago, the three-dimensional structure of a hammer-
head ribozyme (HHRz) TS analogue was described.155 This
vanadate complex revealed important rearrangements compared
to the earlier obtained pre-cleavage HHRz structures. The active
site contracted, placing a guanine (G10.1) closer to the cleavage
site (Fig. 9). This guanine appears similar to G33 in the pistol
ribozyme because it coordinates a divalent ion through N7 and a
backbone phosphate (A9). Although the distance to the scissile
phosphate is farther compared to the arrangement in pistol, the
HHRz vanadate structure also suggested a stabilization of the
transition state by water-mediated H-bonding with the scissile
phosphate. A second divalent ion was found in innersphere
coordination to O6 of a guanine (G12). This guanine fulfills
the role of a general base in the hammerhead ribozyme active
site with the metal ion tuning the pKa value to support depro-
tonation of the attacking 20-OH of C17. Importantly, the deletion
of O6 in a G12Ap mutant of the hammerhead ribozyme was
responsible for a significant rate reduction (by a factor of 103),209
and this finding underlines the importance of innersphere
coordination of the metal ion to this atom. Distinct to HHRz,
the role of the second Mg2+ with respect to pistol cleavage
acceleration is minor, however, it appears to stabilize the con-
formation of the cyclophosphate product in the complex.
Twister-sister ribozyme
The twister-sister ribozyme adopts either a three-way or four-way
junctional fold comprising internal and terminal loops with
conserved residues resembling those in the twister ribozyme
(Fig. 10A).165 Self-cleavage occurs between cytidine (C62) and
an adenosine (A63) of an internal loop that is on the opposite
side when compared to the twister ribozyme secondary
structure model.
To date only two structures exist of this ribozyme, representing
the precatalytic state (Fig. 10B and C).210,211 Both structures
display the terminal loop with a high number of conserved
nucleotides projecting from a large continuous helical fold onto
the minor groove of the partially zippered-up internal L1
loop segment associated with a second continuous helix
(Fig. 10B and C). The two structures, however, show significant
distinctions in the active site arrangement (Fig. 10D and E).
For the four-way junctional fold, the bases C and A at the
cleavage site are splayed apart. The C is directed outwards and
A directed inwards and held tightly within the ribozyme core
(Fig. 10D).210 Remarkably, the modeled 20-OH is far from
adopting an ideal angle for in-line attack at the scissile phos-
phate. Importantly, the N1H of an active pocket guanine (G5)
and an innersphere water of a hydrated Mg2+ cation (labeled
M1 in Fig. 10D) form hydrogen bonds to the non bridging
phosphate oxygens, fixating the scissile phosphate. In addition,
Fig. 9 Hammerhead ribozyme. Pocket for active site C17-U1.1 (transition
state mimic; vanadate) for purposes of comparison with the pistol ribo-
zyme pocket. Crucial atom distances indicating possible interactions are
shown by dashed lines. The values in black represent distances in Å.
Fig. 10 Twister-sister ribozyme. (A) Secondary structure model of the
consensus sequence of twister-sister (left) and comparison to twister
(right). (B) Three-dimensional structure in cartoon presentation of the dC
modified 4-way junctional (4WJ) ribozyme and (C) the dC modified 3-way
junctional (3WJ) ribozyme. Note the differences at the cleavage site
(yellow): splayed apart (dC62 and A63) for 4WJ, and stacked in double
helix (dC54 and A55) for 3WJ. Black triangles indicate the cleavage
positions. (D) Pocket for dC–A active site in the 2 structure of the 4WJ
ribozyme with emphasis on the G5–scissile phosphate interaction. (E) Pocket
for dC–A active site pocket in the structure of the 3WJ ribozyme.
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a second hydrated Mg2+ (labeled M2 in Fig. 10B) is located in a
way that an innersphere water is in hydrogen bond distance of
the (modeled) 20-O nucleophile of C. Mutations of the active
pocket guanine and inwardly-oriented and anchored active site
adenine abolish cleavage, while mutations of the flexible and
outwardly-oriented cytosine have no influence on activity.
In the three-way junctional fold, the in-line conformation
required for attack of the 20-OH at the scissile phosphate is also
not adopted (Fig. 10E).211 Interestingly, the 20-OH nucleophile
is within hydrogen bonding distance of an innersphere water of
a hydrated Mg2+ cation (labeled M3 in Fig. 10E). Furthermore,
the C and A are stacked, and C adopts a fixated and A a flexible
arrangement in the three-way junctional structure,211 unlike
to the alignments of C and A in the four-way junctional
structure.210 Moreover, the oxygens of the scissile phosphate
do not interact with a G and also not with a hydrated Mg2+ in
the three-way junctional structure,211 as it is in the four-way
junctional structure.210 These stark differences observed for the
catalytic pocket of the pre-catalytic states attest the necessity for
further studies that reveal the architecture of transition state
mimics of the twister-sister ribozyme at high resolution to shed
light on the chemical mechanism.
Based on the structure of the 3WJ twister-sister ribozyme, a
model for the functional active state of the ribozyme from
molecular simulation proposed either direct or Mg2+ mediated
involvement of a cytosine (C7) in the active site pocket for the
cleavage reaction.212
Hatchet ribozyme
The hatchet motif is unusual because its cleavage site is located
at the very 50 end of its secondary structure model.165,185,212 The
only other ribozymes that are wholly downstream of their
cleavage sites are the HDV family of ribozymes213 and the
glmS riboswitch–ribozyme, keeping in mind that the latter is
dependent on the cofactor GlcN6P for its activity.160,161
The hatchet ribozyme sequence contains thirteen highly
conserved residues interspersed amongst bulge elements linking
stem segments but no obvious tertiary interactions could be
deduced from the biochemical data alone.185,212 RNA strand
scission in the hatchet ribozyme requires divalent Mg2+ cations.
The maximum cleavage rate kobs was determined to approx.
4 min1, reaching a plateau on increasing the pH to 7.5.
Rate measurements on scissile phosphorothioate analogues
suggested a crucial contact between the scissile phosphate
and a functional group in the active site of the ribozyme.214
Moreover, the pH reactivity profile was determined and implied
that the attacking 20-OH is activated by a functional moiety that
has a pKa value of about 7.
214
To date, only one crystal structure of a hatchet ribozyme is
available, representing the post-cleavage state (Fig. 11).215 The
ribozyme crystallised as dimer with strand swap in the 30-end
region. Mutations in the 4 nt dimerisation site revealed that the
monomeric form is fully active. The hatchet ribozyme com-
prises a pair of two parallel-aligned long helices P2–P1 (H12)
and P3–L3–P4 (H34) (Fig. 11A). The long-distance interaction
between terminal loop L1 and internal loop L3 identified in
the tertiary fold, together with several bridged nucleotides in
internal L2, appear to anchor the relative alignments of H12
and H34.
Despite the cleavage site being located at the 50 end of the
sequence, it is positioned in the center of the tertiary structure
of the hatchet ribozyme (Fig. 11A).215 Moreover, the dispersed
conserved nucleotides in the secondary structure of the hatchet
ribozyme are all brought into proximity and aligned around
the cleavage site. Their alignments result in the generation
of a pocket with the leaving group 50-OH of U1 pointing
toward the cavity (Fig. 11B). The dimensions of the pocket are
capable of accommodating both the (modeled) C(1) and the
scissile phosphate linked to U1 (Fig. 11C). The C(1) and
U1 are splayed apart and the 20-OH is ideally positioned for
an in-line attack at the scissile phosphate (Fig. 11D). The
model further highlights likely interactions of C(1) and the
to-be-cleaved phosphate with functional groups of nucleosides
in the pocket which are potential candidates for general
base and general acid catalysis. In particular, this concerns
a G of a conserved G–C base pair (G31–C64) whose mutation to
7-deazaguanine renders the ribozyme inactive. To gain deeper
insights into hatchet catalysis, structure determination of pre-
cleavage and transition state mimics are needed.
Fig. 11 Hatchet ribozyme. (A) Three-dimensional fold in cartoon presen-
tation of the ribozyme product (post-cleavage state). The site of cleavage
is labeled with a yellow star. (B) The ribozyme product is shown in surface
representation with U1 in sticks (yellow). A cavity is visible adjacent to the
leaving group 50-OH of U1 which seems of sufficient size to accommodate
the scissile phosphate and a nucleoside 50 of it. (C) Model of the hatchet
ribozyme comprising the C(1)–U1 cleavage site shown in sticks (yellow)
and otherwise in surface representation. C(1) was modeled based on the
shape of the cavity on the hatchet ribozyme surface. (D) The proposed
model for the precatalytic state of the ribozyme, in which C(1) forms
extensive hydrogen bonds with nucleosides and the phosphate backbone
in the pocket. The modelled conformation is in-line and indicates func-
tional groups of nucleotides that may contribute to catalysis. In particular,
N7 of G31 is a candidate based on the finding that a 7-deaza-G31 mutant
was inactive.
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Comparison of hatchet and HDV ribozymes. Only one
other ribozyme class is known with the cleavage site at the very
50 end of its consensus sequence, namely the HDV family of
ribozymes.213 Similar to hatchet, the first crystal structure of an
HDV RNA was solved for the cleaved product.157 The HDV
ribozyme comprises five helical regions that are arranged in a
nested double pseudoknot, forming two coaxial stacks (Fig. 12A).
The parallel alignment of these two long stacks is comparable
to the hatchet ribozyme, although its helical composition is
distinct. Moreover, the cleavage sites of both ribozymes (yellow
star in Fig. 11A and 12A) are located in the center of each tertiary
fold and the active site formation involved junctional regions.
Another obvious similarity of hatchet and HDV active sites is that
their 50-terminal nucleosides (nucleoside 30 from the scissile
phosphate) are Watson–Crick base paired at the terminus of a
stem (Fig. 12B and C).
The first HDV ribozyme structure pointed at a nucleoside
(C75) in its active site pocket that was later ascertained to play a
key role in catalysis. The hatchet product structure now points
at a specific guanine (G31) in its pocket. Whether this nucleo-
side participates in general acid–base catalysis has yet to be
determined. In the product structures of both ribozymes, no
Mg2+ ions were identified in the vicinity of the cleavage site.
However, the crystal structures of the pre-cleavage state that
followed for HDV RNA later on, revealed a Mg2+ ion in the
pocket.216,217 Today the general view is that the protonated C75
of HDV is directly interacting with the scissile phosphate
during the cleavage process,218 which is additionally supported
by electrostatic interactions with the metal ion bound in the
active site.216–220
RNA-cleaving deoxyribozymes
The first DNA enzyme with endoribonuclease activity was iden-
tified by Breaker and Joyce using in vitro selection in 1994.221
Since then, numerous examples of RNA-cleaving DNA enzymes
have been reported, all of them derived from synthetic DNA
libraries.222,223 Up to now, no natural catalytically active DNA has
been found. RNA-cleaving DNA enzymes are practically useful
tools for fundamental biochemical research,224 and deoxyribo-
zymes have been explored as mRNA-targeting agents for the
downregulation of disease-relevant genes (before the advent of
other potent gene regulation approaches such as RNAi and
CRISPR/Cas strategies).225 The largest and most diverse field of
applications is found in bio- and nanotechnology, where DNA-
zymes are used as components of analytical devices for biosen-
sors and logic gates.226–228 Recent reviews summarize diverse
metal ion-dependent transesterification DNA enzymes and their
applications.228–230 In many analytical applications, the sub-
strate is a DNA strand with a single ribonucleotide incorporated,
linked to a FRET pair, with donor and acceptor placed before
and after the cleavage site.231 A DNA sequence with a single
ribonucleotide was also used as a substrate for in vitro selections
that aimed at generalizing the substrate sequence tolerance at
the cleavage site.232,233 Nearly all 16 dinucleotide junctions
can now be cleaved, but only few DNA enzymes were tested on
all-RNA substrates. Compared to the single-ribonucleotide-
containing substrate, significantly reduced cleavage rates and
yields were observed.224 Nevertheless, interesting analytical
applications have been reported, including quantitative analysis
of Na+ ion concentrations in cells.234 Below, we summarize
structural and mechanistic aspects of RNA-cleaving DNA
enzymes, and discuss recently reported DNA enzymes for the
detection of posttranscriptional RNA modifications.
Structure and mechanism of the 8–17 DNA enzyme.
Mechanistically, the best-characterised RNA-cleaving deoxyri-
bozyme is the 8–17 DNAzyme.235,236 The structure of 8–17 in
complex with a non-cleavable substrate analogue (i.e. a DNA
strand) was reported in 2017.237 To facilitate crystallisation, the
DNA was complexed with a DNA polymerase protein derived
from the African swine fever virus (AsfvPolX). The protein was
found to bind to the outer extremities of the binding arm
duplexes, in distant location from the active site (Fig. 13).
The structure revealed a surprising twisted pseudoknot in
the catalytic core, with long-range base-pairing interactions
that could not be predicted from a large set of biochemical
data.222,236 The pseudoknot contains very short base-paired
regions, of 3 and 2 bp respectively. The 2 bp interaction consists
of the Watson–Crick base pair G6–C12 and a non-canonical
Hoogsten-sugar edge base pair A5–G13. The pseudoknot archi-
tecture positions the guanine G13 to serve as a general base to
activate the 20-OH by proton abstraction (not present in the
structure), consistent with biochemical data.238 Divalent metal
ions are essential for activity of 8–17, with Mg2+ and Mn2+ as the
most common cofactors for practical use.224 Interestingly, Pb2+ has
been shown as the most active metal ion for 8–17 activation.239
The structure of 8–17 was solved with Pb2+, and a partially
occupied metal ion binding site was found that suggests
interaction with O6 and/or N7 of G6 and with the non-
bridging phosphate oxygen atoms, likely via water-mediated
contacts in the hydration shell. Evidence for general acid–base
Fig. 12 HDV ribozyme. (A) Three-dimensional fold in cartoon presenta-
tion of the HDV ribozyme product (post-cleavage state). The site of
cleavage is labeled with a yellow star. (B) Pocket of the HDV cleavage site
with G1 shown in sticks (yellow). C75 (red) acts as general acid in d
catalysis. (C) Pocket of the hatchet cleavage site with U1 shown in sticks
(yellow). G31 (red) has been proposed to play a crucial role in catalysis. Its
precise role remains to be determined.
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catalysis was also established by (bio)chemical atomic muta-
genesis data,238 and analysed in detail in combination with
molecular dynamics (MD) simulations.241,242 Such investiga-
tions may reveal the degree of shared mechanistic features
between artificial RNA-cleaving DNA catalysts and naturally
evolved ribozyme counterparts. However, the MD simulations
were carried out with Pb2+, and it is currently unclear if the
results are transferable to the more biologically relevant Mg2+.
This question is of special interest, since FRET analyses
revealed different folding landscapes with different metal
ions.243,244 Thus, future structures of the 8–17 DNAzyme in
complex with an RNA substrate strand carrying a 20-OMe or 20-F
modified nucleotide at the cleavage site, and in the presence of
Mg2+ are highly desirable. Along the same lines, it will be
interesting to study the structural features of Na+-specific
DNAzymes, for which a single point mutation has recently been
described to result in switching the catalytic mechanism from
general base to general acid catalysis.245
RNA modification-sensitive DNAzymes. Recently, RNA-cleaving
deoxyribozymes were evolved to recognize chemical nucleobase
modifications on the RNA substrate. Such DNAzymes may become
beneficial tools for epitranscriptomic research for the validation
of distinct sites of posttranscriptional modifications.240,246,247
Moreover, they can become defining components in screening
assays for activators or inhibitors of writer or eraser enzymes.
The 20-O-methylation of rRNA was the first posttranscriptional
RNA modification studied by RNA-cleaving deoxyribozymes.246
For mechanistic reasons, methylation at the cleavage site inhibits
the DNA enzyme, and the methylated RNA remains intact.
In contrast, nucleobase modifications 5-methylcytidine (m5C),
5-methyluridine (m5U), and pseudouridine (c) in tRNA did not
interfere with DNA-catalysed RNA cleavage. Both modifications
barely influenced cleavage rate and yield of 10–23 DNAzymes,
and were detected at the 50-terminus of the downstream frag-
ment by TLC and LC-MS methods.247,248 However, 10–23 is
limited to cleaving purine|pyrimidine (R|Y) junctions, and thus
is not useful for the analysis of modified purine nucleotides.
Selective DNA enzymes that result in distinct cleavage events
for modified RNA and unmodified RNA would simplify the
analysis. The first RNA-cleaving DNA enzyme that showed
accelerated cleavage of modified RNA was shown to distinguish
N6-methyladenosine (m6A) from unmodified adenosine at the
cleavage site.240 Surprisingly, better selectivity was obtained in
the opposite direction, i.e. it was easier to find DNA enzymes
that are strongly inhibited by m6A. The VMC10 DNA enzyme
(Fig. 13D) efficiently cleaved unmodified RNA and left
methylated RNA intact. Such enzymes are useful for the enrich-
ment of sparsely methylated RNA, and can be used to validate
predicted m6A sites in isolated cellular RNA.145,249
Besides the development of tools for epitranscriptomic
research, it is of fundamental interest to understand if
and how DNA enzymes distinguish different methylation/
modification states of the target RNA. In the absence of any
crystal structure, the responsible supramolecular contacts remain
speculative. While m6A-specific reader proteins recognize m6A via
a methyl–p interaction with heteroaromatic amino acid side
chains (such as the tryptophan cage in YTH proteins),250 no
analogous interactions are known in RNA/DNA-only structures.
However, preferred structural motifs are known in RNA, in which
m6A together with Mg2+ has a stabilizing effect,251 and others in
which m6A modulates base-pairing patterns,252–254 or RNA
annealing kinetics.255 In the DNA active site of VMC10, it is
thus conceivable, that the methyl group of m6A interferes with
an essential H-bonding interaction within the core of the
deoxyribozyme and thus inhibits catalytic activity. Interestingly,
the predicted VMC10 secondary structure shares features remi-
niscent of 8–17 (Fig. 13). However, no interference of m6A can
be predicted from the orientation of the nucleotides around the
cleavage site.237 Likely, additional contacts are formed between
the RNA substrate and the guanine-rich bulge between the
predicted P2 and P3 stems.
Compared to m6A, much stronger activating effects on DNA
enzymes were found with a larger nucleobase modification,
N6-isopentenyl adenosine (i6A).256 The prenylated adenosine is
a natural tRNA modification that is conserved in certain tRNAs
in bacteria and eukaryotes,257 and the hydrophobic nature of
i6A was suggested to facilitate its association to membranes.258
It remains to be determined which type of non-covalent inter-
actions are most influential to explain the pronounced prefer-
ence of 2500-fold faster cleavage of i6A RNA compared to
unmodified RNA.256
The findings on m6A and i6A-selective DNAzymes spur
further interest in the development of DNA catalysts targeting
other RNA modifications. For example, it would be quite
spectacular to evolve DNAzymes that can discriminate the three
natural singly methylated cytidine isomers m3C, m4C and m5C
from unmodified cytidine. Ideally, individual DNAzymes
should selectively cleave only one out of the four targets. Since
Fig. 13 8–17 and VMC10 DNAzymes. (A) Tertiary structure and
(B) secondary structure overview of RNA-cleaving 8–17 DNAzyme
(crystallized with AsfvPolX protein, grey), GG kink at the cleavage site in
yellow. (C) Excerpt of the catalytic core showing the G13 acting as a base
for deprotonation of 20-OH (missing in the structure) and Pb2+ coordinating
to G6. (D) Secondary structure of m6A-sensitive VMC10 DNAzyme.240
Features suggested to resemble similar functions compared to 8–17 are
shown in matching colors to (B).
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none of the previously reported 8–17 analogues is particularly
good at cleaving N|C junctions in all-RNA substrates,232,259
advanced in vitro evolution strategies need to be developed to
overcome the tyranny of the 8–17 motif.236 Deep sequencing
analyses of enriched selection libraries with in situ analyses of
cleavage activity and selectivity26,260 may lead to the identifi-
cation of new catalytic DNA motifs for the site-specific inter-
rogation of difficult-to-cleave RNA substrates and isomers of
posttranscriptional RNA modifications.
DNA-cleaving DNA enzymes
In contrast to RNA transesterification, the site-specific cleavage of
DNA is more challenging to achieve, because the internal nucleo-
phile for attack at the scissile phosphate is missing. Several different
cleavagemechanism were employed by DNA-cleaving DNA enzymes,
including Cu2+-mediated oxidative cleavage, and strand breaks at
apurinic sites after DNA-catalysed deglycosylation.261 A serendipitous
discovery of a bimetallic deoxyribozyme that required Zn2+ and
Mn2+ for hydrolytic phosphodiester cleavage activity, generated
well-defined DNA fragments with impressive rate enhance-
ments and multiple turnover.262 Further selections in the
presence of different metals produced DNA-cleaving sequences
that required only Zn2+,263 or were reactive with low concentra-
tions of lanthanides.264 An elegant selection strategy involving
circular DNA revealed generally applicable Zn2+-dependent
DNA-cleaving DNAzymes,265,266 that were engineered for mass
production of DNA origami.267 Deoxyribozyme pairs were con-
structed into self-cleaving cassettes that enabled the generation
of all necessary single strands for several DNA origami struc-
tures from large-scale bacteriophage cultures.
Nucleic acid-catalysed formation of phosphodiester bonds in
RNA
Formally, the reverse of phosphodiester cleavage, is the for-
mation of a new 30–50 linkage between two RNA fragments. This
connection can be furnished by different mechanisms. The
microscopic reversibility of the cleavage by transesterification,
initiated by the 20-OH attack on the scissile phosphodiester,
suggests that regioselective opening of the cyclic phosphate by
attack from the 50-OH results in regiospecific ligation. In the
laboratory, this reaction is employed by the twin ribozyme for
RNA labelling and mutagenesis.268 The twin ribozyme is an
engineered version of the hairpin ribozyme found in the
satellite RNA of tobacco ringspot virus, and thus it is a variant
of the small nucleolytic ribozymes described above.
In contrast to opening of 20,30-cyclophosphates, an alterna-
tive practically useful ligation reaction involves the 30-OH as the
nucleophile and an activated 50-phosphate as the electrophile.
Most commonly, 50-triphosphates are used, but 50-adenylates,
nicotinamides, or substituted 50-phosphorimidazolides have
also been employed.269–271 Fundamentally, this reaction resem-
bles the elongation step catalysed by RNA polymerases, and is
thus also of great interest in the context of origin of life
research and the RNA world, in which an RNA polymerase
ribozyme would have been able to copy functional RNA
molecules.118,272
RNA-ligating ribozymes & polymerase ribozymes
In contrast to the detailed knowledge available on RNA/DNA-
catalysed RNA cleavage reactions summarized above, very little
is known on structures and mechanisms of RNA ligase and RNA
polymerase ribozymes. The crystal structures for two types of
RNA ligases were reported between 2007 and 2011,273–275 but
since then no additional structures have become available of
any other ligase or polymerase ribozymes.
The class I ligase276 and the L1 ligase277 share the arrange-
ment of the ligation substrates in a discontinuous double helix,
firmly hybridized to a complementary template strand (Fig. 14).
An engineered version of the class I ligase is still the fastest
ribozyme described today with a kcat of 100 min
1.274 The
crystal structures of the pre- and post-catalytic states reveal
complex catalytic strategies. In the pre-catalytic state of the
class I ligase, the 50-triphosphate takes an unexpected orienta-
tion in the major groove of the primer–template duplex.273 The
30-OH nucleophile is positioned for in-line attack with the help
of a Mg2+ ion, and interactions with nucleobase and ribose
functional groups also play important roles.273
Structural analogues of the L1 ligase, were derived from
independent selections, originally in the absence of cytidine
(R3 ligase), and then re-selected with all four nucleotides (R3C
ligase) and further evolved for enhanced catalytic efficiencies
(F1 ligase).278,279 Recently, large-scale mutagenesis and the
evaluation of more than 10 000 sequence variants resulted in
the systematic minimization of the catalytic core to 18 nucleo-
tides (minF1).280 The class I and R3C ligases were the starting
points for the evolution of RNA polymerase ribozymes, and
their evolutionary history was recently summarized.272 Some of
the most exciting and creative strategies towards the synthesis
of long more complex RNAs involved the evolution in ice,281 the
evolution of a cross-chiral RNA ligase ribozyme,282 and the
templated polymerization of RNA trinucleotide triphosphates
(triplet building blocks).283 A highly optimized ribozyme was
able to synthesize DNA polymers on an RNA template.284 The
most recent ribozyme generation was shown to synthesise
its own evolutionary ancestor in three pieces, which self-
assembled into an active class I RNA ligase.285
Fig. 14 Class I ligase and L1 ligase ribozymes. Positioning of the reactive
nucleotides in the active centre of class I ligase274 (A) and L1 ligase275 (B)
ribozymes. Nucleotides at ligation junction are coloured in cyan, and pre-
and postcatalytic structures are compared.
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RNA-ligation catalysed by DNA (deoxyribozymes)
The generally useful RNA ligase deoxyribozyme named 9DB1
was reported by Silverman in 2005.286 It was derived from an
in vitro selection experiment, in which a selection pressure
demanded the regioselective formation of only 30,50 linkages.286
The crystal structure of 9DB1 was reported in 2016 as the first
three-dimensional structure of a DNA enzyme in a catalytically
relevant conformation.287 The structure provided unprece-
dented insights into the architecture of an active site made of
DNA. The 9DB1 DNA complexed with its RNA ligation product
forms a double pseudoknot in which two thymidine loop
nucleotides interact with the A–G RNA nucleotides directly at
the ligation junction (Fig. 15). These interactions could not be
predicted from the available biochemical data.288–290 The
insights from the crystal structure enabled engineering of the
deoxyribozyme to broaden the substrate scope of RNA ligation.
The crystal structure revealed a static picture of the post-
catalytic product-bound state of the DNA enzyme and was
unable to explain the involvement of magnesium ions as
cofactors for accelerating RNA ligation. An internucleotide
phosphodiester oxygen was suggested to make a critical
contact,287 and this was supported by computational analyses
and molecular dynamics simulations that revealed a plateau in
the energy landscape, suggesting a concerted asynchronous
transition state.291 The concerted phosphoryl and proton
transfer pathway was found to be endergonic, and the release
of the protonated pyrophosphate in complex with Mg2+ ions
was suggested to drive the reaction towards ligation. The
direct protonation of the phosphate needs further experimental
confirmation, since slight rearrangements in the active site
could support an alternative explanation, as recently suggested
by density functional theory (DFT) calculations of an alternative
active-site model of 9DB1.292 However, this earlier model did
not consider the involvement of metal ions, which are required
for catalysis.286,290
On the other hand, the proposed contacts of the metal ions
in the active site with the triphosphate and RNA substrate
were experimentally validated by phosphorothioate substitu-
tion and analysis of reaction rates.291 Nevertheless, structural
models in the pre-catalytic state with bound metal ions and the
pyrophosphate leaving group, with a transition state analogue
or with an a,b-non-hydrolysable triphosphate analogue are highly
desired. The structure revealed a broader range of sugar–
phosphate backbone conformations in the DNA core than
in natural and synthetic ribozymes.287 This suggests that the
missing of the 20-OH groups of DNA expands the conforma-
tional flexibility of DNA relative to RNA, to allow additional
modes of interaction. This concept is likely to be employed by
other deoxyribozymes, for which the structure is not yet known.
(Deoxy)ribozymes for covalent RNA labelling
RNA-ligating ribozymes and deoxyribozymes can not only
activate the 30-terminal hydroxy group, but the active site can
be directed to a specific internal nucleotide and activate the
20-OH for nucleophilic attack on a triphosphate, resulting in
the formation of 20,50-branched RNA.293 Surprisingly, such
branching reactions were identified when in vitro selections
for RNA-ligating deoxyribozymes were carried out in the
absence of a selection pressure for formation of the linear
native connection.294 These unexpected DNA enzymes were
turned into useful tools for generating artificial lariat RNAs
(that contained the native linkage at the branch site),295–297 and
for the attachment of oligonucleotides that modulated the
folding and function of larger RNAs and ribozymes.298,299
Moreover, the branch-forming deoxyribozyme 10DM24 was
engineered for RNA labelling.300,301 Together with the finding,
that the ligation reaction was significantly accelerated by
lanthanide ions (e.g. Tb3+),302 fast and efficient RNA labelling
was achieved by the attachment of functionalized or fluores-
cently labelled guanines via the 20,50-branched linkage.303 Sine
lanthanide ions cannot completely replace divalent Mg2+ or
Mn2+, they are more likely to play a supporting structural role
rather than being directly involved in the catalytic mechanism.
The rather complex metal ion requirements of 10DM24 may
be overcome by alternative nucleic acid catalysts. In this
respect, ribozymes for a comparable labelling strategy of RNA
were recently described.304,305 These RNA catalysts resulted
from a targeted in vitro selection strategy that used a structured
RNA library to guide the ribozyme to the predetermined
labelling site, and were directly selected with ATP derivatives as
small-molecule labelling reagents.305 To enhance the bioortho-
gonality of this RNA labelling strategy, a new generation of
Fig. 15 9DB1 DNAzyme. (A) Reaction catalysed by 9DB1 RNA ligase
deoxyribozyme and secondary structure of DNA enzyme in complex with
ligated RNA product. (B) Global architecture of the DNA catalyst. (C) Active
site of 9DB1. The ligation junction, the base-pairing (magenta) and stacking
(blue) nucleotides, the putatively catalytic dA13 phosphate, oriented by the
long-range base pair (green) brings the pro-Sp non bridging oxygen in
proximity to the 30-oxygen of A-1. (D) Schematic illustration of the
transition state model from QM/MM,291 suggesting a concerted phos-
phoryl and proton transfer involving the coordination of two metal ions.
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ribozymes was developed that used antiviral nucleotide
analogues as substrates.304 In particular, tenofovir-transferase
ribozymes were obtained that are orthogonal to the adenylyl-
transferase ribozymes, and generate a branched phosphonate
linkage instead of the phosphate linkage (Fig. 16). Site-specific
installation of FRET reporters was demonstrated on small and
large RNAs (5S, 16S and 23S rRNA) in the context of total
cellular RNA.304,305 These studies pave the way for future
evolution of catalytic RNA labelling tools in cells.
Outlook on further fundamental studies on ribozymes and
deoxyribozymes
Besides important insights into the mechanism of ribozymes
and DNAzymes that are anticipated from chemical and biophy-
sical studies, as well as from crystal structures of ribozymes/
DNAzymes (pre- and post-catalytic states, transition state ana-
logues), exploring their conformational dynamics by modern
single molecule FRET and NMR spectroscopic methods would
contribute to a deeper understanding of their catalytic activity.
The expected micro- to milliseconds timescale of nucleoside
dynamics in the active site, and of nucleosides at tertiary
interactions should be accessible by using selective 13C labelling
patterns and relaxation dispersion NMR experiments.306–310 In
this way, populations of nucleoside conformations (concerning
e.g. ribose pucker, glycosidic bond angles, etc.) that are crucial
for approaching the transition state of phosphodiester cleavage
could be revealed. Finally, using selective 15N labelling patterns,
nucleobase tautomers and/or ionic forms potentially involved in
catalysis could be made visible and this would represent a first
direct spectroscopic verification in ribozymes/DNAzymes.
Additional exciting future directions target the evolution
of nucleic acid catalysts for reactions not yet known to be
catalysed by RNA and DNA. A particular challenge is to find
ribozymes and deoxyribozymes that modulate the modification
state of RNA, directly by installing RNA modifications or
by removing them, rather than degrading modified RNA
or the unmodified counterpart. Fundamental research will
then advance nucleic acid enzymes beyond analytical tools,
and will allow entrance to the synthetic biology regime as an
active modulator.
Summary
This review summarised common versus distinct structural and
functional strategies that are applied by fluorogen-activating
RNA aptamers, recently discovered bacterial riboswitches, and
ribozymes/DNAzymes that catalyse phosphodiester chemistry.
Fundamental studies on their structure and folding, their
dynamics and reactivity, and their modification and labelling
are continuously performed because the understanding of
nucleic acids inherent molecular properties is needed to harness
these modules for advanced applications in biotechnology and
biomedicine.
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